(Q33346480)

26 July 2017

title

Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome (English)

1 reference

26 July 2017

Richard L Siegler

1

1 reference

26 July 2017

Tom G Obrig

2

1 reference

26 July 2017

Theodore J Pysher

3

1 reference

26 July 2017

Vernon L Tesh

4

1 reference

26 July 2017

Nathaniel D Denkers

5

1 reference

26 July 2017

Fletcher B Taylor

6

1 reference

26 July 2017

publication date

10 January 2003

1 reference

26 July 2017

1 reference

26 July 2017

volume

18

1 reference

26 July 2017

issue

2

1 reference

26 July 2017

page(s)

92-96

1 reference

Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees

26 July 2017

cites work

1 reference

12 December 2020

Kinetic analysis of binding between Shiga toxin and receptor glycolipid Gb3Cer by surface plasmon resonance

1 reference

12 December 2020

Infections with Escherichia coli O157:H7 in Washington State. The first year of statewide disease surveillance.

1 reference

12 December 2020

1 reference

12 December 2020

In vivo modulation of coagulation and fibrinolysis by recombinant glycosylated human interleukin-6 in baboons

1 reference

12 December 2020

Properties of strains of Escherichia coli belonging to serogroup O157 with special reference to production of Vero cytotoxins VT1 and VT2

1 reference

12 December 2020

Detection of verocytotoxin bound to circulating polymorphonuclear leukocytes of patients with hemolytic uremic syndrome

1 reference

12 December 2020

Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects

1 reference

12 December 2020

Specific Interaction of Escherichia coli 0157:H7-Derived Shiga-like Toxin II with Human Renal Endothelial Cells

1 reference

12 December 2020

Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum

1 reference

12 December 2020

Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-1 beta, IL-6 and plasminogen activator inhibitors from monocytes in vitro

1 reference

12 December 2020

Verotoxin-binding in human renal sections.

1 reference

12 December 2020

Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. Evidence for B subunit modulation of a subunit function

1 reference

12 December 2020

The hemolytic uremic syndrome

1 reference

12 December 2020

Verotoxins and their glycolipid receptors.

1 reference

12 December 2020

Response to single and divided doses of Shiga toxin-1 in a primate model of hemolytic uremic syndrome

1 reference

12 December 2020

Evidence for participation of the macrophage in Shiga-like toxin II-induced lethality in mice

1 reference

12 December 2020

Characterization of the baboon responses to Shiga-like toxin: descriptive study of a new primate model of toxic responses to Stx-1

1 reference

12 December 2020

Shiga toxin-1 regulation of cytokine production by human proximal tubule cells

1 reference

12 December 2020

Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolytic-uremic syndrome

1 reference

12 December 2020

Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice

1 reference

12 December 2020

The mode of action of Shiga toxin on peptide elongation of eukaryotic protein synthesis

1 reference

12 December 2020

Response to Shiga toxin-1, with and without lipopolysaccharide, in a primate model of hemolytic uremic syndrome.

1 reference

12 December 2020

Binding and transfer of verocytotoxin by polymorphonuclear leukocytes in hemolytic uremic syndrome

1 reference

12 December 2020

Toxin entry: retrograde transport through the secretory pathway

1 reference

12 December 2020

10.1007/S00467-002-1035-7

Identifiers

DOI

0 references

Dimensions Publication ID

1075235454

0 references

1 reference